BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 25117743)

  • 41. Uterine Artery Embolization for Symptomatic Adenomyosis: 7-Year Clinical Follow-up Using UFS-Qol Questionnaire.
    de Bruijn AM; Smink M; Hehenkamp WJK; Nijenhuis RJ; Smeets AJ; Boekkooi F; Reuwer PJHM; Van Rooij WJ; Lohle PNM
    Cardiovasc Intervent Radiol; 2017 Sep; 40(9):1344-1350. PubMed ID: 28516272
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term follow-up outcome and reintervention analysis of ultrasound-guided high intensity focused ultrasound treatment for uterine fibroids.
    Li W; Jiang Z; Deng X; Xu D
    Int J Hyperthermia; 2020; 37(1):1046-1051. PubMed ID: 32878497
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Initial experience of uterine fibroid embolization using porous gelatin sponge particles.
    Katsumori T; Kasahara T; Oda M; Kotani T
    Cardiovasc Intervent Radiol; 2011 Jun; 34(3):513-21. PubMed ID: 20574795
    [TBL] [Abstract][Full Text] [Related]  

  • 44. FIRSTT study: randomized controlled trial of uterine artery embolization vs focused ultrasound surgery.
    Laughlin-Tommaso S; Barnard EP; AbdElmagied AM; Vaughan LE; Weaver AL; Hesley GK; Woodrum DA; Jacoby VL; Kohi MP; Price TM; Nieves A; Miller MJ; Borah BJ; Moriarty JP; Gorny KR; Leppert PC; Severson AL; Lemens MA; Stewart EA
    Am J Obstet Gynecol; 2019 Feb; 220(2):174.e1-174.e13. PubMed ID: 30696556
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term outcomes of ultrasound guided high intensity focused ultrasound ablation for patients with uterine fibroids classified by T2WI: a multicenter retrospective study.
    Yuan Y; Xu W; Shen H; Lin Z; Xu F; Shi Q; Zhan P; Liu M; Shu J; Chen J; Xing HR
    Int J Hyperthermia; 2023; 40(1):2212887. PubMed ID: 37202174
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The efficacy and safety of MR-HIFU and US-HIFU in treating uterine fibroids with the volume <300 cm
    Yu L; Zhu S; Zhang H; Wang A; Sun G; Liang J; Wang X
    Int J Hyperthermia; 2021; 38(1):1126-1132. PubMed ID: 34325610
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Uterine artery embolization for symptomatic uterine fibroids.
    Gupta JK; Sinha A; Lumsden MA; Hickey M
    Cochrane Database Syst Rev; 2014 Dec; (12):CD005073. PubMed ID: 25541260
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeted vessel ablation for more efficient magnetic resonance-guided high-intensity focused ultrasound ablation of uterine fibroids.
    Voogt MJ; van Stralen M; Ikink ME; Deckers R; Vincken KL; Bartels LW; Mali WP; van den Bosch MA
    Cardiovasc Intervent Radiol; 2012 Oct; 35(5):1205-10. PubMed ID: 22146977
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Randomized comparison of uterine artery embolization (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): subanalysis of 5-year MRI findings.
    Ananthakrishnan G; Murray L; Ritchie M; Murray G; Bryden F; Lassman S; Lumsden MA; Moss JG
    Cardiovasc Intervent Radiol; 2013 Jun; 36(3):676-81. PubMed ID: 23070101
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and safety of ultrasound-guided high-intensity focused ultrasound for uterine fibroids: a preliminary experience.
    Cheung VYT; Lam TPW; Jenkins CR; Lam SW; Cheung GKI; Chan SSY; Choi WK
    J Obstet Gynaecol; 2019 Aug; 39(6):833-839. PubMed ID: 31006301
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Magnetic resonance imaging-guided focused ultrasound treatment of pedunculated subserosal uterine fibroids: a preliminary report.
    Park H; Yoon SW; Kim KA; Jung Kim D; Jung SG
    J Vasc Interv Radiol; 2012 Dec; 23(12):1589-93. PubMed ID: 23099002
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Uterine artery embolization for symptomatic fibroids in postmenopausal women.
    Lee SJ; Kim MD; Kim GM; Won JY; Park SI; Lee DY
    Clin Imaging; 2016; 40(1):106-9. PubMed ID: 26372352
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Five-year clinical outcomes of uterine artery embolization for symptomatic leiomyomas: An analysis of risk factors for reintervention.
    Yoon JK; Han K; Kim MD; Kim GM; Kwon JH; Won JY; Lee DY
    Eur J Radiol; 2018 Dec; 109():83-87. PubMed ID: 30527317
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Review of influential clinical factors in reducing the risk of unsuccessful MRI-guided HIFU treatment outcome of uterine fibroids.
    Duc NM; Keserci B
    Diagn Interv Radiol; 2018 Sep; 24(5):283-291. PubMed ID: 30211682
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Uterine artery embolization for symptomatic fibroids: long-term changes in disease-specific symptoms and quality of life.
    Scheurig-Muenkler C; Lembcke A; Froeling V; Maurer M; Hamm B; Kroencke TJ
    Hum Reprod; 2011 Aug; 26(8):2036-42. PubMed ID: 21642637
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety and efficacy of US-guided high-intensity focused ultrasound for treatment of submucosal fibroids.
    Wang W; Wang Y; Wang T; Wang J; Wang L; Tang J
    Eur Radiol; 2012 Nov; 22(11):2553-8. PubMed ID: 22653287
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Non-surgical techniques for the treatment of uterine fibroids: Uterine artery embolization (UAE), high intensity focused ultrasound (HIFU) and radiofrequency ablation (RFA).
    Cañete Palomo ML
    Med Clin (Barc); 2023 Oct; 161 Suppl 1():S27-S31. PubMed ID: 37923511
    [No Abstract]   [Full Text] [Related]  

  • 58. A randomised trial of treating fibroids with either embolisation or myomectomy to measure the effect on quality of life among women wishing to avoid hysterectomy (the FEMME study): study protocol for a randomised controlled trial.
    McPherson K; Manyonda I; Lumsden MA; Belli AM; Moss J; Wu O; Middleton L; Daniels J
    Trials; 2014 Nov; 15():468. PubMed ID: 25432688
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cost-effectiveness of uterine-preserving procedures for the treatment of uterine fibroid symptoms in the USA.
    Cain-Nielsen AH; Moriarty JP; Stewart EA; Borah BJ
    J Comp Eff Res; 2014 Sep; 3(5):503-14. PubMed ID: 24878319
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Comparing Options for Management: PAtient-centered REsults for Uterine Fibroids (COMPARE-UF) registry: rationale and design.
    Stewart EA; Lytle BL; Thomas L; Wegienka GR; Jacoby V; Diamond MP; Nicholson WK; Anchan RM; Venable S; Wallace K; Marsh EE; Maxwell GL; Borah BJ; Catherino WH; Myers ER
    Am J Obstet Gynecol; 2018 Jul; 219(1):95.e1-95.e10. PubMed ID: 29750955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.